The Vanguard Group 13D and 13G filings for Amneal Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 4:58 pm Purchase |
2023-12-29 | 13G | Amneal Pharmaceuticals, Inc. AMRX |
The Vanguard Group | 13,642,387 4.450% |
594,319 (+4.55%) |
Filing |
| 2023-02-09 11:07 am Purchase |
2022-12-30 | 13G | Amneal Pharmaceuticals, Inc. AMRX |
The Vanguard Group | 13,048,068 8.610% |
1,473,173 (+12.73%) |
Filing |
| 2022-02-09 3:24 pm Purchase |
2021-12-31 | 13G | Amneal Pharmaceuticals, Inc. AMRX |
The Vanguard Group | 11,574,895 7.750% |
592,064 (+5.39%) |
Filing |
| 2021-02-10 10:30 am Purchase |
2020-12-31 | 13G | Amneal Pharmaceuticals, Inc. AMRX |
The Vanguard Group | 10,982,831 7.440% |
797,756 (+7.83%) |
Filing |